{"id":436,"date":"2023-11-16T16:11:00","date_gmt":"2023-11-16T08:11:00","guid":{"rendered":"http:\/\/en.metabiopharma.com\/?p=436"},"modified":"2024-03-20T16:15:11","modified_gmt":"2024-03-20T08:15:11","slug":"dr_anjin_xianyu_co-founder_and_cto_of_meta_pharmaceuticals_was_invited_to_participate_in_the_xint","status":"publish","type":"post","link":"http:\/\/en.metabiopharma.com\/index.php\/2023\/11\/16\/dr_anjin_xianyu_co-founder_and_cto_of_meta_pharmaceuticals_was_invited_to_participate_in_the_xint\/","title":{"rendered":"Dr. Anjin Xianyu, Co-Founder and CTO of META Pharmaceuticals, was invited to participate in the Xintian Shenzhen-Hong Kong Cooperation and Development Forum (\u65b0\u7530\u6df1\u6e2f\u5408\u4f5c\u767c\u5c55\u8bba\u575b).\ufffc"},"content":{"rendered":"\n

On November 13th<\/strong>, the Xintian Shenzhen-Hong Kong Cooperation and Development Forum<\/strong>, hosted by Dystar Group<\/strong>, was held in the Shenzhen Futian International Biomedical Industrial Park<\/strong>. The forum centered around<\/strong>\u00a0the development of the biomedical industry<\/strong>\u00a0in the Loop Cooperation Zone<\/strong>\u00a0and delved into<\/strong>\u00a0the opportunities and challenges<\/strong>\u00a0of cooperation<\/strong>\u00a0between Xintian<\/strong>\u00a0and the Loop Cooperation Zone<\/strong>\u00a0in the field of biomedicine<\/strong>.<\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n

On that day<\/strong>, a number of Hong Kong political experts<\/strong>, including Mr. Lau Yip Keung<\/strong>, Chairman of the Hong Kong New Territories Heung Yee Kuk<\/strong>, Mr. Yau Wing Kwong<\/strong>, and Mr. Lau Man Kwan<\/strong>, members of the Hong Kong New Territories Heung Yee Kuk<\/strong>, participated in the forum<\/strong>. During the event, Mr. Lau<\/strong>\u00a0expressed his active support for promoting the development<\/strong>\u00a0of Hong Kong\u2019s New Territories North Metro Area<\/strong>. He also expressed hope<\/strong>\u00a0to strengthen ties<\/strong>\u00a0with Shenzhen<\/strong>\u00a0and explore collaboration<\/strong>\u00a0in areas such as science and technology innovation<\/strong>, biomedicine<\/strong>, and more. The goal is to contribute to the development<\/strong>\u00a0of the Loop Cooperation Zone<\/strong>.<\/p>\n\n\n\n

Dr. Anjin Xianyu<\/strong>, Co-founder and CTO<\/strong>\u00a0of META Pharmaceuticals<\/strong>, was also invited to participate<\/strong>\u00a0in the event. Together with other representatives<\/strong>\u00a0from biomedical enterprises<\/strong>, they engaged in an in-depth discussion<\/strong>\u00a0on cross-border investment and financing<\/strong>, as well as the various possibilities of cooperation<\/strong>\u00a0within the Xintian Loop<\/strong>. Following the forum, Chairman Liu Yeqiang<\/strong>\u00a0and a group of representatives visited META Pharmaceuticals<\/strong>\u00a0and highly recognized META\u2019s new biological mechanism<\/strong>.<\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n
\"\"
Picture|Chairman Lau and two Heung Yee Kuk members, Mr. Yau Wing Kwong and Mr. Lau Man Kwan, visit META Pharmaceuticals<\/figcaption><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"

On November 13th, the Xintian Shenzhen-Hong Kong Cooper […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"_links":{"self":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/436"}],"collection":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/comments?post=436"}],"version-history":[{"count":1,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/436\/revisions"}],"predecessor-version":[{"id":442,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/436\/revisions\/442"}],"wp:attachment":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/media?parent=436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/categories?post=436"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/tags?post=436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}